Compare HROW & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | KARO |
|---|---|---|
| Founded | 1998 | 2001 |
| Country | United States | Singapore |
| Employees | 373 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2020 |
| Metric | HROW | KARO |
|---|---|---|
| Price | $46.15 | $57.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $69.86 | $59.33 |
| AVG Volume (30 Days) | ★ 853.2K | 85.0K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.62 | $22.17 |
| Revenue Next Year | $50.77 | $16.74 |
| P/E Ratio | ★ N/A | $24.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.54 | $41.25 |
| 52 Week High | $54.98 | $60.53 |
| Indicator | HROW | KARO |
|---|---|---|
| Relative Strength Index (RSI) | 70.69 | 75.88 |
| Support Level | $44.30 | $43.38 |
| Resistance Level | $51.01 | $60.53 |
| Average True Range (ATR) | 2.20 | 2.18 |
| MACD | 0.36 | 1.07 |
| Stochastic Oscillator | 91.44 | 94.23 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Karooooo Ltd is a provider of an operational intelligence platform. Through its cloud platform, the company enables fleet and asset management, fuel management, workforce management, logistics, safety, including AI-assisted video safety, compliance, risk, and environmental impact management. Its segments are: Cartrack, which generates the majority of revenue, provides an operational intelligence platform that maximizes the value of transportation, operations, and workflow data through insightful real-time data analytics to connected vehicles and equipment, and Karooooo Logistics provides a software application enabling the management of last-mile B2B delivery and general operational logistics (Delivery-as-a-Service or DaaS). It generates the majority of its revenue from South Africa.